Coloplast launches a new catheter in the United States


Get instant alerts when news breaks on your stocks. Claim your one week free trial for StreetInsider Premium here.

Coloplast SpeediCath® The Flex Set catheter developed for people living with bladder and urine problems is now licensed in the United States and will launch in November 2022.

The new SpeediCath Flex set with a “non-contact dry sleeve” and an omni-directional tip is available as a catheter and bag solution, also known as a closed system. All SpeediCath® catheters feature Triple Action Coating Technology designed to reduce the risk of urethral injury and urinary tract infections (UTIs)*1 and are an option for people with spinal cord injuries ( SCI).

“With SpeediCath Flex Set, we are introducing an important solution for people living with spinal cord injury and many other health conditions. We are confident that its innovative new design will make a big difference for our users, improving their catheterization routine by many ways,” said Senior Vice President Manu Varma, Chronic Care North America.

A recent estimate2 shows that the annual incidence of IBS is approximately 18,000 cases each year in the United States and that the majority of patients with IBS will suffer from neurogenic bladder dysfunction (NBD). Patients with NBD have significant challenges to their well-being, ranging from incontinence, kidney failure and urinary tract infections to bladder stones and a generally poor quality of life.3

The SpeediCath Flex Set is a gentle all-in-one solution. It has features that help patients catheterize with confidence at home or away, helping them manage their condition and maintain a healthy lifestyle. Find more information about SpeediCath Flex Set here.

About Coloplast Incontinence Care Products Coloplast aims to provide effective solutions for bladder and bowel control. By continually gathering feedback from clinicians and patients, the company innovates to address urinary issues such as incontinence and retention. Coloplast also offers additional support through its Coloplast® Care program, which provides product and lifestyle advice, inspiration and educational resources for people living with bladder issues.

About Coloplast Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. Visit for more information. This information is intended as an educational resource and presented for general informational purposes only. It is not intended to constitute medical or business advice or in any way substitute for the independent medical judgment of a trained and licensed physician with respect to patient needs or circumstances. Before use, please refer to the product’s “Instructions for Use” for intended use and relevant safety information.

* Compared to uncoated catheters

  1. Rognoni C, Tarricone R. Intermittent catheterization with hydrophilic and non-hydrophilic urinary catheters: systematic review of the literature and meta-analyses. BMC Urol. 2017 Jan 10;17(1):4. doi:10.1186/s12894-016-0191-1.PMID:28073354; PMCID: PMC5225586.
  2. The National Spinal Cord Injury Database 2020 SCI Fact Sheet
  3. Neurogenic bladder in patients with spinal cord injury – PMC (

Worldwide press contact Peter Mønster, Senior Media Relations Officer +45 4911 2623 [email protected] US press contact Kate Merwin, Head of Communications 612-286-2455 [email protected]

main logo

Source: Coloplast A/S


Comments are closed.